Riquel Gonzalez, DPM
Foot & Ankle Surgery · Hialeah, FLNPI 1457693566
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Vilex LLC accounts for 76.3% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2023 at $22,961 and has fallen 92.5% since, to $1,733 in 2025. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 166 payments — averaging $316.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vilex LLC$40K
- Musculoskeletal Transplant Foundation Inc.$3K
- Arthrex$2K
- Novartis$1K
- HNM Total Recon$1K
- Stryker$1K
- plus $4K from 29 others
Across 51 payments — averaging $10,979 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cleerly, Inc.$452K
- Sun Pharmaceutical Industries Inc.$81K
- Royal Biologics, Inc.$27K
What the payments were for
- Consulting fees$26,78651%
- Travel & lodging$13,52026%
- Food & beverage$10,31420%
- Education$1,8374%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vilex LLC | 32 | $40,032 |
| Musculoskeletal Transplant Foundation Inc. | 11 | $3,192 |
| Arthrex | 5 | $1,568 |
| Novartis | 4 | $1,137 |
| HNM Total Recon | 1 | $1,078 |
| Stryker(2 entities) | 30 | $1,068 |
| HNM Stainless, LLC | 4 | $839 |
| Southern Edge Orthopaedics, Inc. | 1 | $637 |
| Organogenesis Inc. | 13 | $618 |
| Smith+Nephew | 14 | $432 |
| Paragon 28, Inc. | 2 | $331 |
| Treace Medical Concepts, Inc. | 5 | $190 |
| Kerecis Limited | 3 | $158 |
| Royal Biologics, Inc. | 2 | $130 |
| Triad Life Sciences Inc. | 1 | $119 |
| In2bones USA, LLC | 1 | $118 |
| Biotissue Holdings Inc. | 4 | $108 |
| Bioventus LLC | 6 | $106 |
| Medela LLC | 5 | $91 |
| Integra Lifesciences Corporation | 1 | $88 |
| Amgen(2 entities) | 3 | $61 |
| Melinta Therapeutics, LLC | 3 | $50 |
| Embody, Inc. | 1 | $39 |
| Biocomposites Inc | 1 | $38 |
| Heron Therapeutics, Inc. | 2 | $37 |
| Zimmer Biomet | 1 | $30 |
| Amniox Medical, Inc. | 2 | $23 |
| Abbott | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Misonix Inc | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $17 |
| Acell, Inc. | 1 | $17 |
| Stimwave Technologies Incorporated | 1 | $16 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HINTERMANN$32,309
- DYNEX$7,358
- SALVATION$291
- APEX TAR$201
- Lapiplasty System$151
- TRAUMA$130
- InnovaMatrix AC$119
- TriWay TTC Nail$118
- CoLink$118
- PitStop$118
- Puraply Antimicrobial$117
- PuraPly$110
- CryoCord$105
How this compares
$52,457 in reported general payments places this provider in the 90th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 1,310 | $28,910 |
| Ammonium Lactate | 1,085 | $22,285 |
| JubliaEfinaconazole | 14 | $13,113 |
| XareltoRivaroxaban | 11 | $5,896 |
| SantylCollagenase Clostridium Hist. | 17 | $5,714 |
| Linezolid | 15 | $4,355 |
| Gentamicin Sulfate | 72 | $4,203 |
| Ciclopirox | 78 | $3,308 |
| Ketoconazole | 184 | $3,047 |
| Diclofenac Sodium | 145 | $2,406 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 121 | $2,280 |
| Gabapentin | 234 | $2,167 |
| Mupirocin | 184 | $1,828 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 136 | $1,230 |
| Oxycodone Hcl | 31 | $1,100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $432 | $5,71417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 850 foot & ankle surgery providers in Florida.
Other foot & ankle surgery in Hialeah
- Mario CalaHialeah$541K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Christopher ReevesLake Mary$424K
- Ettore VulcanoMiami Beach$411K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.